JAMES SIMS: Open Payments
NPI 1932183530 · BELLAIRE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,911 in 60 payments from 5 companies in 2025. Trend: 2023 $2,680 · 2024 $1,325 · 2025 $2,911
Food & beverage: $1,833Travel & lodging: $1,078
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $1,328 |
| Gilead Sciences, Inc. | 21 | $789 |
| ViiV Healthcare Company | 25 | $696 |
| PFIZER INC. | 2 | $70 |
| Theratechnologies Inc. | 1 | $29 |
Products named: DOVATO, RUKOBIA, Yeztugo, Epclusa, CABENUVA, PIFELTRO, OCTAGAM IMMUNE GLOBULIN (HUMAN), EGRIFTA.
Industry payments across TX — which companies pay providers there.
